Efficacy and Safety of Viagra® (Sildenafil Citrate) in Men.

Erectile dysfunction (ED) is a premiss with a high preponderance in patients with cardiovascular disease (CVD) due to several factors. The same risk factors (diabetes, evaporation, and hypertension) are implicated in the pathogenesis of both diseases. In increase, certain drugs used in the tending of CVD may induce ED ( eg, thiazide diuretics, digoxin, and beta blockers).
The aim of this knowledge base, which was presented at the Scientific Sessions of the 49th American Complex of Cardiology group discussion was the categorisation of the efficacy and base hit of sildenafil for the idiom of ED in patients with CVD.
A amount of 224 men with ED and CVD, who were not under nitrate therapy, were randomized to either sildenafil (n=136) or medicine (n=88) in this 12-week, double-blind study; 83% of the men had hypertension, 19% had previous myocardial infarction; 17% had coronary blood vessel disease, 17% had angina pectoris, 14% had previous coronary conductor, 12% had peripheral vascular disease, and 5% had congestive kernel occurrence. The medicine of viagra was started at 50 mg, which could be adjusted to 100 mg or 25 mg based on efficacy and tolerability. The medicament was taken approximately 1 hour before sexual bodily function, not more than once daily, 10 multiplication per unit of time on norm.
This is a part of article Efficacy and Safety of Viagra® (Sildenafil Citrate) in Men. Taken from "Sildenafil Citrate Soft Tabs" Information Blog